NFKB1 and hepatocellular carcinoma: The compound suppresses PI3K/AKT/NF-κB signaling in ultraviolet B (UVB)-irradiated keratinocytes [110] and regulates glutamine metabolism through ERK/c-Myc inhibition in hepatocellular carcinoma [111].